Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab. Arpín E C, Sobrino T G, Vivero C D, Del Campo Amigo Jorrín M, Regal A R, González J P, Bouzas M L Neurodegener Dis Manag. 2016 Feb; 6(1):5-12. PMID: 26782312. Abstract CommentRecommendBookmarkWatch